TaiwanJ Pharmaceuticals has signed a $26 million contract with Newsoara Biopharma to license out its drug candidate JKB-...
Foresee Pharmaceuticals, a Taiwan and US-based biopharmaceutical company listed on the Taipei Exchange has announced tha...
A team led by Dr. Chi-Huey Wong, Distinguished Research Fellow, Academia Sinica in Taiwan, in collaboration with OBI sci...
An exclusive license agreement for the commercialisation of Foresee Pharmaceutical's (6576.TWO) novel FP-001 program (le...
Taiwan Liposome Company, a clinical-stage specialty pharmaceutical company dedicated to the development and commercializ...
US based Precision Therapeutics Inc. has announced that its Skyline Medical division, producer of the FDA-approved and C...
TWi Biotechnology (TWiB), a clinical stage biopharmaceutical company focused on development of novel products for rare d...
TaiwanJ Pharmaceuticals, a specialty pharmaceutical company dedicated to the development and commercialization of small ...
CellMax Life, a US based diagnostics company with a proprietary technology to detect precancer and cancer cells in blood...
Dr. Yu-Chin Hsu, Deputy Minister of Science and Technology of Taiwan, the opening of Taiwan Tech Arena (TTA) at Eureka P...
Taiwan is known as the heart of the world’s tech supply chain, offering high-quality products in electronics. Now ...
Windtree Therapeutics, a biotechnology company focused on developing aerosolized KL4 surfactant therapies for respirator...
Panther Orthopedics, Inc., a medical device company is pleased to announce the successful clinical use of its innovative...
Chugai Pharmaceuticals announced that Chugai Pharma Taiwan, a wholly owned subsidiary of Chugai, obtained approval...
Taiwanese start-up MedicalTek has developed the world’s first and only endoscope visualization system, MonoStereo&...
Taiwan Healthcare+ Expo 2018, opened today at Taipei City, is being attended by 25 delegations from important organisati...
OBI Pharma, Inc., a Taiwan biopharma company, has announced that the U.S. Food and Drug Administration (FDA) h...
Senhwa Biosciences Inc. has announced that FDA has approved its IND application for basal cell carcinoma (BCC). To accel...
